National Cancer Institute TitleKeywordsActivity CodeFOALOI Due DateApplication Due Date (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environmentsprevention, controlR01, R03, R21NOT-CA-25-0121/8/2028 (NOSI): Advancing Diet and Physical Activity Biomarkers for Assessing Lifestyle Interventions in Cancer Prevention and Cancer Interception Researchbiomarkers, lifestyle interventions, prevention, interception, diet, physical activityR01, R03, R21NOT-CA-24-0741/8/2027 (NOSI): NCI's Interest in Research on Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatmentmultidisciplinary, collaborationNOT-CA-25-0071/8/2028 (NOSI): Survivorship Research for People Living with Advanced and Metastatic Cancerspalliative, quality-of-life, psychosocialNOT-CA-25-0241/8/2028 (NOSI): Communication and Decision-Making in a Complex and Dynamic Cancer Treatment Environmentenvironment, patient-providerNOT-CA-25-0069/8/2028 (NOSI): Mechanisms Driving Obesity and Prostate Cancer Riskprostate, risk, preventionR00, R01, R21, K99NOT-CA-25-0021/8/2028 (NOSI): Research on rare cancers across the cancer control continuumtreatment, diagnosis, epidemiologyR01, R03, R21, R34, U34, P01NOT-CA-25-0101/8/2028 Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)molecular, biomarkers, therapies, clinical UH2, UH3PAR-25-0742/14/2026 NCMRR Early Career Research Award (R03 Clinical Trial Optional)Biomedical Informatics, Cancer Informatics, Health Data Management, Cancer ResearchR03PAR-25-1246/18/0275 Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)Pediatric, birth defects, data analysis, geneticR03PAR-25-1096/18/0275 Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)molecular, biomarkers, therapies, clinical UH3PAR-25-0752/14/2026 Health disparitiesPAR-25-2416/18/0275 Clinical Characterization of Cancer Therapy - induced Adverse Sequelae and Mechanism - based Interventional Strategies (R01 Clinical Trial Optional)collaborative, therapies, basic, translational, clinical, biomarkers, R01PAR-25-1451/6/20262/5/2026 Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)dissemination, implementation, evidence-based interventions, publicR01PAR-25-1441/6/20262/5/2026 Can’t find what you’re looking for? Please contact researchdevelopment@cancer.ufl.edu for assistance in finding additional funding opportunities.
